Methods for using dual glycan binding AAV vectors

Disclosed herein are methods for delivery of a nucleic acid to a subject for treatment of a disease, comprising administering a modified adeno-associated virus (AAV) vector that contains a therapeutic transgene comprising the nucleic acid in expressible form, further comprising a modified AAV2 …